首页 > 最新文献

Complementary Medicine Research最新文献

英文 中文
Low Inter-Rater Reliability and Reproducibility of Neck Reflex/"Adler-Langer" Points in Neural Therapy Diagnostics but Increased Pressure Pain Threshold after Therapy: Results of a Randomized Controlled Observer-Blind Trial. 神经疗法诊断中颈部反射/"阿德勒-朗格 "点的评分者间可靠性和可重复性较低,但治疗后压力-疼痛阈值提高--随机对照观察者-盲法试验结果。
IF 1.1 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-05-14 DOI: 10.1159/000539230
Kyung-Eun Choi, Jan Grünert, Marc Werner, Holger Cramer, Dennis Anheyer, Gustav Dobos, Felix J Saha

Background: Neck reflex points or Adler-Langer points are commonly used in neural therapy to detect so-called interference fields. Chronic irritations or inflammations in the sinuses, teeth, tonsils, or ears are supposed to induce tension and tenderness of the soft tissues and short muscles in the upper cervical spine. The individual treatment strategy is based on the results of diagnostic Adler-Langer point palpation. This study investigated the inter- and intra-rater reliability and explored treatment effects.

Methods: We performed a randomized controlled trial with 104 inpatients (80.8% female, 51.8 ± 12.74 years) of a German department for internal and integrative medicine. Patients were randomized to individual neural therapy according to the pathological findings (n = 48) or no treatment (n = 56). In each patient, three experienced raters (20-45 years of experience in neural therapy) and two novice raters (medical students) rated Adler-Langer points rigidity on a standardized rating scale ("strong," "weak," "none"). The patients independently evaluated the tenderness on palpation of the eight points using the same scale. Pressure pain thresholds were assessed at the eight Adler-Langer points. All patients were retested after 30 min. The five raters were blinded to treatment allocation and assessments of the other raters. Video recordings were obtained to assess the consistency of the areas tested by the different raters.

Results: Agreement between patients and raters (Cohen's kappa = 0.161-0.400) and inter-rater reliability were low (Fleiss kappa = 0.132-0.150). Moreover, the individual agreement (pre-post comparisons in untreated patients) was similarly low even in experienced raters (Cohen's kappa = 0.099-0.173). Video documentation suggests that raters do not place their fingers in the correct segments (percentage of correct position: 42.0-60.6%). Pressure pain thresholds at five of the eight Adler-Langer points showed significant changes after treatment compared to none in the control group.

Conclusion: Under this artificial experimental setting, this method of Adler-Langer point palpation has not proven to be a reliable diagnostic tool. But it could be shown that, as claimed by the method, the tenderness in five of eight Adler-Langer points decreased after neural therapy.

背景介绍颈部反射点或阿德勒-朗格点通常用于神经疗法,以检测所谓的干扰场。鼻窦、牙齿、扁桃体或耳朵的慢性刺激或炎症会引起上颈椎软组织和短肌肉的紧张和疼痛。个人治疗策略以诊断性阿德勒-朗格穴触诊结果为基础。本研究调查了评分者之间和评分者内部的可靠性,并探讨了治疗效果:我们对德国一家内科和综合科的 104 名住院患者(80.8% 为女性,51.812.74 岁)进行了随机对照试验。患者根据病理结果随机接受个体神经疗法(48 人)或不接受治疗(56 人)。每名患者均由三名经验丰富的评定者(神经疗法经验 20-45 年)和两名新手评定者(医科学生)根据标准化评分表("强"、"弱"、"无")对阿德勒-朗格穴僵硬度进行评分。患者使用相同的量表独立评估触诊八个穴位时的压痛感。对八个阿德勒-朗格穴的压痛阈值进行评估。30 分钟后对所有患者进行复测。五位评定者对治疗分配和其他评定者的评定结果都是盲测。为评估不同评分者测试区域的一致性,还进行了录像:患者与评分者之间的一致性(Cohen's Kappa=.161-.400)和评分者之间的可靠性均较低(Fleiss-Kappa=.132-.150)。此外,即使是经验丰富的评分员,其个人一致性(未经治疗患者的前后比较)也同样较低(科恩卡帕=.099-.173)。视频记录表明,评分者并没有将手指放在正确的区段(正确位置百分比为 42.0-60.6%)。八个阿德勒-朗格穴中有五个穴位的压痛阈值在治疗后出现了显著变化,而对照组则没有:在这种人工实验环境下,阿德勒-朗格穴触诊法并未被证明是一种可靠的诊断工具。但可以证明的是,正如该方法所声称的那样,经过神经疗法后,八个阿德勒-朗格穴中有五个穴位的压痛有所减轻。
{"title":"Low Inter-Rater Reliability and Reproducibility of Neck Reflex/\"Adler-Langer\" Points in Neural Therapy Diagnostics but Increased Pressure Pain Threshold after Therapy: Results of a Randomized Controlled Observer-Blind Trial.","authors":"Kyung-Eun Choi, Jan Grünert, Marc Werner, Holger Cramer, Dennis Anheyer, Gustav Dobos, Felix J Saha","doi":"10.1159/000539230","DOIUrl":"10.1159/000539230","url":null,"abstract":"<p><strong>Background: </strong>Neck reflex points or Adler-Langer points are commonly used in neural therapy to detect so-called interference fields. Chronic irritations or inflammations in the sinuses, teeth, tonsils, or ears are supposed to induce tension and tenderness of the soft tissues and short muscles in the upper cervical spine. The individual treatment strategy is based on the results of diagnostic Adler-Langer point palpation. This study investigated the inter- and intra-rater reliability and explored treatment effects.</p><p><strong>Methods: </strong>We performed a randomized controlled trial with 104 inpatients (80.8% female, 51.8 ± 12.74 years) of a German department for internal and integrative medicine. Patients were randomized to individual neural therapy according to the pathological findings (n = 48) or no treatment (n = 56). In each patient, three experienced raters (20-45 years of experience in neural therapy) and two novice raters (medical students) rated Adler-Langer points rigidity on a standardized rating scale (\"strong,\" \"weak,\" \"none\"). The patients independently evaluated the tenderness on palpation of the eight points using the same scale. Pressure pain thresholds were assessed at the eight Adler-Langer points. All patients were retested after 30 min. The five raters were blinded to treatment allocation and assessments of the other raters. Video recordings were obtained to assess the consistency of the areas tested by the different raters.</p><p><strong>Results: </strong>Agreement between patients and raters (Cohen's kappa = 0.161-0.400) and inter-rater reliability were low (Fleiss kappa = 0.132-0.150). Moreover, the individual agreement (pre-post comparisons in untreated patients) was similarly low even in experienced raters (Cohen's kappa = 0.099-0.173). Video documentation suggests that raters do not place their fingers in the correct segments (percentage of correct position: 42.0-60.6%). Pressure pain thresholds at five of the eight Adler-Langer points showed significant changes after treatment compared to none in the control group.</p><p><strong>Conclusion: </strong>Under this artificial experimental setting, this method of Adler-Langer point palpation has not proven to be a reliable diagnostic tool. But it could be shown that, as claimed by the method, the tenderness in five of eight Adler-Langer points decreased after neural therapy.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"359-366"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140921594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Forest Therapy as a Nature-Based Intervention: An Option for Neurological Rehabilitation? 森林疗法作为一种基于自然的干预:神经康复的选择?
IF 1.8 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2023-10-12 DOI: 10.1159/000534533
Josef G Heckmann, Martin Kiem, Gisela Immich
<p><strong>Background: </strong>Forest therapy demonstrates positive effects on mood, immune system, stress levels, and general well-being. Studies on depression, stress-related illnesses, sleep disorders, and arterial hypertension have provided evidence-based proof of this.</p><p><strong>Summary: </strong>The aim of this review was to examine the possible effects of forest therapy with regard to its evidence in the treatment of chronic neurological diseases such as stroke in the rehabilitation phase, Parkinson's disease, dementia, and multiple sclerosis. Therefore, the electronic databases Medline, Scopus, and Cochrane were searched for such clinical trials for the years 1970 to mid-2023 without language restriction. The literature search revealed only few studies with positive indications but too few cases to be able to make generalizable evidence-based statements. In terms of improvement in the Hamilton Depression Scale analysis of two studies in stroke patients showed slight benefits in the forest therapy group (standard mean difference -0.43; 95% CI: -0.76 to -0.10; p < 0.01). One observational study revealed a higher rate of stroke survival in patients living in marked greenness. Few nature-based interventions in dementia patients showed certain benefits in particular details.</p><p><strong>Key messages: </strong>There are no evidence-based results on the benefit of forest therapy for chronic neurological diseases. However, there are hints that forest therapy could have a positive benefit. Therefore, a proposal for forest therapy as a component of multimodal neurological rehabilitation is presented.</p><p><p><title>Hintergrund</title>Die Waldtherapie zeigt positive Auswirkungen auf die Stimmung, das Immunsystem, das Stressniveau und das allgemeine Wohlbefinden. Studien zu Depressionen, stressbedingten Erkrankungen, Schlafstörungen und arteriellem Bluthochdruck haben dies evidenzbasiert belegt.<title>Zusammenfassung</title>Ziel dieser Übersichtsarbeit war es, die möglichen Wirkungen der Waldtherapie im Hinblick auf ihre Evidenz bei der Behandlung chronischer neurologischer Erkrankungen wie Schlaganfall in der Rehabilitationsphase, Morbus Parkinson, Demenz und Multiple Sklerose zu untersuchen. Dazu wurden die elektronischen Datenbanken Medline, Scopus und Cochrane für die Jahre 1970 bis Mitte 2023 ohne sprachliche Einschränkung nach solchen klinischen Studien durchsucht. Die Literaturrecherche ergab nur wenige Studien mit positiven Indikationen, aber zu wenigen Fällen, um verallgemeinerbare evidenzbasierte Aussagen machen zu können. Im Hinblick auf Verbesserung in der Hamilton Depressionsskala zeigte die Analyse von 2 Studien bei Schlaganfallpatienten leichte Vorteile der Waldtherapiegruppen (Standard Mean Difference −0.43; 95% CI: -0.76- -0,10; <italic>p</italic> < 0.01). Eine Beobachtungsstudie ergab eine höhere Schlaganfall-Überlebensrate bei Patienten, die in ausgeprägtem Grün leben. Einige naturbasierte Interventionen bei Demenzpat
背景:森林疗法对情绪、免疫系统、压力水平和总体健康有积极影响。对抑郁症、压力相关疾病、睡眠障碍和动脉高压的研究已经提供了循证证据。综述:本综述的目的是研究森林疗法在治疗慢性神经系统疾病方面的可能效果,如康复期中风、帕金森病、痴呆症和多发性硬化症。因此,在电子数据库Medline、Scopus和Cochrane中搜索了1970年至2023年年中的此类临床试验,没有语言限制。文献检索显示,只有少数研究具有积极的适应症,但病例太少,无法做出普遍的循证声明。就汉密尔顿抑郁量表的改善而言,对两项针对中风患者的研究的分析显示,森林治疗组略有益处(标准平均差-0.43;95%置信区间-0.76--0.10;p关键信息:森林疗法对慢性神经系统疾病的益处没有循证结果。然而,有迹象表明森林疗法可能具有积极的益处。因此,提出了将森林疗法作为多模式神经康复的一个组成部分的建议。
{"title":"Forest Therapy as a Nature-Based Intervention: An Option for Neurological Rehabilitation?","authors":"Josef G Heckmann, Martin Kiem, Gisela Immich","doi":"10.1159/000534533","DOIUrl":"10.1159/000534533","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Forest therapy demonstrates positive effects on mood, immune system, stress levels, and general well-being. Studies on depression, stress-related illnesses, sleep disorders, and arterial hypertension have provided evidence-based proof of this.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Summary: &lt;/strong&gt;The aim of this review was to examine the possible effects of forest therapy with regard to its evidence in the treatment of chronic neurological diseases such as stroke in the rehabilitation phase, Parkinson's disease, dementia, and multiple sclerosis. Therefore, the electronic databases Medline, Scopus, and Cochrane were searched for such clinical trials for the years 1970 to mid-2023 without language restriction. The literature search revealed only few studies with positive indications but too few cases to be able to make generalizable evidence-based statements. In terms of improvement in the Hamilton Depression Scale analysis of two studies in stroke patients showed slight benefits in the forest therapy group (standard mean difference -0.43; 95% CI: -0.76 to -0.10; p &lt; 0.01). One observational study revealed a higher rate of stroke survival in patients living in marked greenness. Few nature-based interventions in dementia patients showed certain benefits in particular details.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Key messages: &lt;/strong&gt;There are no evidence-based results on the benefit of forest therapy for chronic neurological diseases. However, there are hints that forest therapy could have a positive benefit. Therefore, a proposal for forest therapy as a component of multimodal neurological rehabilitation is presented.&lt;/p&gt;&lt;p&gt;&lt;p&gt;&lt;title&gt;Hintergrund&lt;/title&gt;Die Waldtherapie zeigt positive Auswirkungen auf die Stimmung, das Immunsystem, das Stressniveau und das allgemeine Wohlbefinden. Studien zu Depressionen, stressbedingten Erkrankungen, Schlafstörungen und arteriellem Bluthochdruck haben dies evidenzbasiert belegt.&lt;title&gt;Zusammenfassung&lt;/title&gt;Ziel dieser Übersichtsarbeit war es, die möglichen Wirkungen der Waldtherapie im Hinblick auf ihre Evidenz bei der Behandlung chronischer neurologischer Erkrankungen wie Schlaganfall in der Rehabilitationsphase, Morbus Parkinson, Demenz und Multiple Sklerose zu untersuchen. Dazu wurden die elektronischen Datenbanken Medline, Scopus und Cochrane für die Jahre 1970 bis Mitte 2023 ohne sprachliche Einschränkung nach solchen klinischen Studien durchsucht. Die Literaturrecherche ergab nur wenige Studien mit positiven Indikationen, aber zu wenigen Fällen, um verallgemeinerbare evidenzbasierte Aussagen machen zu können. Im Hinblick auf Verbesserung in der Hamilton Depressionsskala zeigte die Analyse von 2 Studien bei Schlaganfallpatienten leichte Vorteile der Waldtherapiegruppen (Standard Mean Difference −0.43; 95% CI: -0.76- -0,10; &lt;italic&gt;p&lt;/italic&gt; &lt; 0.01). Eine Beobachtungsstudie ergab eine höhere Schlaganfall-Überlebensrate bei Patienten, die in ausgeprägtem Grün leben. Einige naturbasierte Interventionen bei Demenzpat","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"56-63"},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41193814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gegen Qinlian Decoction Combined with Conventional Western Medicine for the Treatment of Infectious Diarrhea: A Systematic Review and Trial Sequential Analysis. 格根秦连煎联合常规西药治疗感染性腹泻:系统回顾与试验序列分析》。
IF 1.1 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-08-13 DOI: 10.1159/000540793
Fei Wang, Qianyan Wu, Qingyuan Zhang, Shuaishuai Ma, Kangyi Wang, Hui Jian, Ying Zhang

Introduction: Infectious diarrhea (ID) is a highly prevalent disease worldwide that poses a substantial risk to human well-being. In China, numerous clinical studies have investigated the efficacy of Gegen Qinlian decoction (GGQLD) in treating ID. However, there is a need for additional rigorous and evidence-based medical research to enhance physicians' confidence in their prescribing practices.

Methods: Seven Chinese and English databases were systematically searched. The Cochrane Risk of Bias tool was used to assess the quality of the included studies. Meta-analysis was conducted using RevMan 5.3, and Stata 16.0 was used for the sensitivity analysis. Trial sequential analysis was performed using TSA v0.9, and GRADEprofiler was utilized to evaluate the quality of evidence.

Results: A total of 12 randomized controlled trials (RCTs) involving 1,240 patients were included. The meta-analysis demonstrated that the combination of GGQLD with conventional Western medicine had better effects on clinical efficacy (relative risk [RR] = 1.15, 95% confidence interval [CI] [1.10, 1.20]), duration of diarrhea symptoms (weighted mean difference [WMD] = -10.96, 95% CI [-11.97, -9.96]), duration of abdominal pain symptoms (WMD = -12.01, 95% CI [-14.12, -9.90]), duration of fever symptoms (WMD = -11.91, 95% CI [-13.39, -10.43]), interleukin-6 levels (WMD = -113.59, 95% CI [-113.03, -108.14]), and tumor necrosis factor-α levels (WMD = -62.18, 95% CI [-65.25, -59.11]) and that no significant adverse reactions occurred (RR = 0.45, 95% CI [0.10, 1.97]). The sample size of the included studies reached the expected size. The quality of evidence for outcome indicators was rated as low or very low.

Conclusions: The combination of GGQLD with conventional Western medicine demonstrates promising efficacy and safety in treating ID. Nonetheless, more high-quality RCTs are required to confirm this conclusion.

背景:感染性腹泻(ID)是一种全球高发疾病,对人类健康构成了巨大威胁。在中国,许多临床研究都探讨了格根秦连煎(GGQLD)治疗感染性腹泻的疗效。然而,还需要更多严格的循证医学研究,以增强医生的处方信心:方法:系统检索了七个中英文数据库。方法:系统检索了 7 个中英文数据库,并使用 Cochrane Risk of Bias 工具评估纳入研究的质量。使用 RevMan 5.3 进行 Meta 分析,使用 Stata 16.0 进行敏感性分析。使用TSA v0.9进行试验序列分析,并使用GRADEprofiler评估证据质量:共纳入了 12 项随机对照试验(RCT),涉及 1240 名患者。荟萃分析表明,GGQLD与常规西药联合治疗在临床疗效(RR=1.15,95% CI [1.10,1.20])、腹泻症状持续时间(WMD=-10.96,95% CI [-11.97,-9.96])、腹痛症状持续时间(WMD=-12.01,95% CI [-14.12,-9.90])、发热症状持续时间(WMD=-11.91,95% CI [-13.39,-10.43])、白细胞介素-6(IL-6)水平(WMD=-113.59,95% CI [-113.03,-108.14])和肿瘤坏死因子-α(TNF-α)水平(WMD=-62.18,95% CI[-65.25,-59.11]),且未出现明显的不良反应(RR = 0.45,95% CI [0.10,1.97])。纳入研究的样本量达到了预期规模。结果指标的证据质量被评为低或很低:结论:GGQLD与传统西药联合治疗ID具有良好的疗效和安全性。尽管如此,还需要更多高质量的 RCT 研究来证实这一结论。
{"title":"Gegen Qinlian Decoction Combined with Conventional Western Medicine for the Treatment of Infectious Diarrhea: A Systematic Review and Trial Sequential Analysis.","authors":"Fei Wang, Qianyan Wu, Qingyuan Zhang, Shuaishuai Ma, Kangyi Wang, Hui Jian, Ying Zhang","doi":"10.1159/000540793","DOIUrl":"10.1159/000540793","url":null,"abstract":"<p><strong>Introduction: </strong>Infectious diarrhea (ID) is a highly prevalent disease worldwide that poses a substantial risk to human well-being. In China, numerous clinical studies have investigated the efficacy of Gegen Qinlian decoction (GGQLD) in treating ID. However, there is a need for additional rigorous and evidence-based medical research to enhance physicians' confidence in their prescribing practices.</p><p><strong>Methods: </strong>Seven Chinese and English databases were systematically searched. The Cochrane Risk of Bias tool was used to assess the quality of the included studies. Meta-analysis was conducted using RevMan 5.3, and Stata 16.0 was used for the sensitivity analysis. Trial sequential analysis was performed using TSA v0.9, and GRADEprofiler was utilized to evaluate the quality of evidence.</p><p><strong>Results: </strong>A total of 12 randomized controlled trials (RCTs) involving 1,240 patients were included. The meta-analysis demonstrated that the combination of GGQLD with conventional Western medicine had better effects on clinical efficacy (relative risk [RR] = 1.15, 95% confidence interval [CI] [1.10, 1.20]), duration of diarrhea symptoms (weighted mean difference [WMD] = -10.96, 95% CI [-11.97, -9.96]), duration of abdominal pain symptoms (WMD = -12.01, 95% CI [-14.12, -9.90]), duration of fever symptoms (WMD = -11.91, 95% CI [-13.39, -10.43]), interleukin-6 levels (WMD = -113.59, 95% CI [-113.03, -108.14]), and tumor necrosis factor-α levels (WMD = -62.18, 95% CI [-65.25, -59.11]) and that no significant adverse reactions occurred (RR = 0.45, 95% CI [0.10, 1.97]). The sample size of the included studies reached the expected size. The quality of evidence for outcome indicators was rated as low or very low.</p><p><strong>Conclusions: </strong>The combination of GGQLD with conventional Western medicine demonstrates promising efficacy and safety in treating ID. Nonetheless, more high-quality RCTs are required to confirm this conclusion.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"461-476"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141975304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe Itch Related to Hard Workload Treated with Acupuncture: Unexpected Results - A Case report. 针灸治疗与工作量大有关的严重瘙痒。意想不到的效果。病例报告。
IF 1.1 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-09-02 DOI: 10.1159/000541191
Lisbeth Dahlin, Anja Finn

Introduction: The effects of work-related stress (WRS) on occupational health often lead to reduced well-being and long-term sick leave. Itching or pruritus, a skin inflammation with a rash that provokes the desire to scratch, often occurs during stressful periods in patients with a history of atopic dermatitis (AD).

Case presentation: This patient suffered from severe WRS together with long-term therapeutically resistant pruritus for 8 years, resulting in severe itching. He was provided with an intervention with acupuncture treatment (AT) to prevent a long-term sick leave. The results showed an unexpected reduction in itching, skin inflammation, and eczema. Additionally, the treatment enhanced the patient's emotional and cognitive well-being and eliminated the need for sick leave.

Conclusion: Acupuncture can be an effective complementary treatment for severe itching related to WRS, in addition to standard medical treatments.

简介与工作有关的压力(WRS)对职业健康的影响往往会导致幸福感下降和长期病假。瘙痒或瘙痒症是一种皮肤炎症,伴有皮疹,会引起搔抓的欲望,经常发生在有特应性皮炎(AD)病史的患者身上:病例介绍:这位患者患有严重的 WRS,并伴有长期治疗耐受性瘙痒症,导致严重瘙痒长达八年之久。为了防止长期病假,他接受了针灸治疗(AT)干预。结果显示,瘙痒、皮肤炎症和湿疹出乎意料地减轻了。此外,治疗还增强了患者的情绪和认知能力,使其不再需要请病假:结论:针灸可作为标准医疗方法之外的一种有效辅助治疗方法,用于治疗与 WRS 相关的严重瘙痒。
{"title":"Severe Itch Related to Hard Workload Treated with Acupuncture: Unexpected Results - A Case report.","authors":"Lisbeth Dahlin, Anja Finn","doi":"10.1159/000541191","DOIUrl":"10.1159/000541191","url":null,"abstract":"<p><strong>Introduction: </strong>The effects of work-related stress (WRS) on occupational health often lead to reduced well-being and long-term sick leave. Itching or pruritus, a skin inflammation with a rash that provokes the desire to scratch, often occurs during stressful periods in patients with a history of atopic dermatitis (AD).</p><p><strong>Case presentation: </strong>This patient suffered from severe WRS together with long-term therapeutically resistant pruritus for 8 years, resulting in severe itching. He was provided with an intervention with acupuncture treatment (AT) to prevent a long-term sick leave. The results showed an unexpected reduction in itching, skin inflammation, and eczema. Additionally, the treatment enhanced the patient's emotional and cognitive well-being and eliminated the need for sick leave.</p><p><strong>Conclusion: </strong>Acupuncture can be an effective complementary treatment for severe itching related to WRS, in addition to standard medical treatments.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"567-571"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11633859/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142119099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prespecified Homeopathic Medicines in the Prevention of Confirmed and Suspected Cases of COVID-19: A Community-Based, Double-Blind, Randomized, Placebo-Controlled Prophylaxis Trial. 预防 COVID-19 确诊和疑似病例的预设顺势疗法药物:一项基于社区、双盲、随机、安慰剂对照的预防性试验。
IF 1.8 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-01-29 DOI: 10.1159/000536395
Abhijit Dutta, Arijit Manna, Shubhamoy Ghosh, Malay Mundle, Madhabananda Saha, Kumar Gourav, Sukhdeb Maiti, Bhargab Chattopadhyay
<p><strong>Introduction: </strong>Homeopathic medicines have been used for decades in the prevention and treatment of infectious diseases. However, the preventive efficacy of specific homeopathic medicines in COVID-19 is not well characterized. This study aimed to evaluate the comparative efficacy of prespecified homeopathic medicines in preventing COVID-19.</p><p><strong>Methods: </strong>A community-based, double-blind, randomized, placebo-controlled trial was conducted on 4,034 participants residing in Ward No. 27 of the Howrah Municipal Corporation in India. Participants were randomized to receive one of three prespecified homeopathic medicines [Influenzinum 30C, Arsenicum album 30C, Anas barbariae hepatis et cordis extractum 200K (Oscillococcinum®)], or placebo. The outcomes were the incidence of laboratory-confirmed and suspected cases of COVID-19 during a follow-up period of 1 month.</p><p><strong>Results: </strong>During the follow-up period, a total of 13 new laboratory-confirmed COVID-19 cases were reported in the study population. Among these, 5 cases in Influenzinum group, 2 cases in Arsenicum album group, 1 case in Oscillococcinum® group, and 5 cases in Placebo group were reported. On the other hand, number of suspected COVID-19 cases was significantly less in all the three homeopathic medicine groups compared to placebo. The least number of suspected cases reported in the Oscillococcinum® group (aOR: 0.058; 95% confidence interval [CI]: 0.029, 0.114), followed by the Arsenicum album (aOR: 0.337; 95% CI: 0.238, 0.475) and Influenzinum (aOR: 0.539; 95% CI: 0.401, 0.726) groups.</p><p><strong>Conclusion: </strong>Prespecified homeopathic medicines, particularly Oscillococcinum® and Arsenicum album 30C, may have a role in preventing COVID-19, especially in reducing the incidence of suspected or COVID-19-like respiratory illnesses. However, the result failed to demonstrate a statistically significant difference in the occurrence of confirmed cases of COVID-19 between the study groups. Further research is needed to evaluate the efficacy of these medicines in different populations and settings.</p><p><p><title>Einleitung</title>Homöopathische Arzneimittel werden seit Jahrzehnten zur Prävention und Behandlung von Infektionskrankheiten eingesetzt. Die Wirksamkeit spezifischer homöopathischer Arzneimittel zur Prophylaxe von COVID-19 ist jedoch nicht gut untersucht. Mit dieser Studie sollte die vergleichende Wirksamkeit spezifischer homöopathischer Arzneimittel bei der Prävention von COVID-19 untersucht werden.<title>Methoden</title>Es handelte sich um eine gemeindebasierte, doppelblinde, randomisierte, placebokontrollierte Studie mit 4.034 Teilnehmern, die im Bezirk Nr. 27 der Howrah Municipal Corporation in Indien lebten. Die Teilnehmer erhielten randomisiert eines von drei zuvor festgelegten homöopathischen Arzneimitteln [<italic>Influenzinum</italic> 30C, <italic>Arsenicum album</italic> 30C, <italic>Anas barbariae hepatis et cordis extrac
导言:几十年来,顺势疗法药物一直被用于预防和治疗传染病。然而,特定顺势疗法药物对 COVID-19 的预防效果尚不十分明确。本研究旨在评估预先指定的顺势疗法药物在预防 COVID-19 方面的疗效比较:方法:对居住在印度豪拉市政公司第 27 病区的 4034 名参与者进行了一项基于社区的双盲、随机、安慰剂对照试验。参与者被随机分配接受三种预先指定的顺势疗法药物(炎琥宁 30C、砒霜 30C、阿那斯-巴比妥肝脏和脊髓提取物 200K(Oscilloccinum®))中的一种或安慰剂。结果是在一个月的随访期间,COVID-19 实验室确诊病例和疑似病例的发生率:结果:在随访期间,研究人群中共报告了 13 例经实验室确诊的 COVID-19 新病例。其中,炎琥宁组5例,砒霜组2例,Oscilloccinum®组1例,安慰剂组5例。另一方面,与安慰剂组相比,所有三个顺势疗法组的 COVID-19 疑似病例数都明显减少。Oscilloccinum®组的疑似病例数最少(aOR:0.539;95%CI:0.401,0.726),其次是Asenicum album(aOR:0.337;95%CI:0.238,0.475)和Influenzinum(aOR:0.058;95%CI:0.029,0.114)组:结论:预设的顺势疗法药物,尤其是 Oscilloccinum® 和 Arsenicum album 30C 可能对预防 COVID-19 有一定作用,尤其是在降低疑似或类似 COVID-19 的呼吸道疾病发病率方面。然而,研究结果未能证明研究组之间在 COVID-19 确诊病例的发生率方面存在显著的统计学差异。需要进一步开展研究,以评估这些药物在不同人群和环境中的疗效:试验注册:CTRI/2020/09/028122,日期:2020年9月29日。试验注册:CTRI/2020/09/028122,日期:2020 年 9 月 29 日。
{"title":"Prespecified Homeopathic Medicines in the Prevention of Confirmed and Suspected Cases of COVID-19: A Community-Based, Double-Blind, Randomized, Placebo-Controlled Prophylaxis Trial.","authors":"Abhijit Dutta, Arijit Manna, Shubhamoy Ghosh, Malay Mundle, Madhabananda Saha, Kumar Gourav, Sukhdeb Maiti, Bhargab Chattopadhyay","doi":"10.1159/000536395","DOIUrl":"10.1159/000536395","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Homeopathic medicines have been used for decades in the prevention and treatment of infectious diseases. However, the preventive efficacy of specific homeopathic medicines in COVID-19 is not well characterized. This study aimed to evaluate the comparative efficacy of prespecified homeopathic medicines in preventing COVID-19.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A community-based, double-blind, randomized, placebo-controlled trial was conducted on 4,034 participants residing in Ward No. 27 of the Howrah Municipal Corporation in India. Participants were randomized to receive one of three prespecified homeopathic medicines [Influenzinum 30C, Arsenicum album 30C, Anas barbariae hepatis et cordis extractum 200K (Oscillococcinum®)], or placebo. The outcomes were the incidence of laboratory-confirmed and suspected cases of COVID-19 during a follow-up period of 1 month.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;During the follow-up period, a total of 13 new laboratory-confirmed COVID-19 cases were reported in the study population. Among these, 5 cases in Influenzinum group, 2 cases in Arsenicum album group, 1 case in Oscillococcinum® group, and 5 cases in Placebo group were reported. On the other hand, number of suspected COVID-19 cases was significantly less in all the three homeopathic medicine groups compared to placebo. The least number of suspected cases reported in the Oscillococcinum® group (aOR: 0.058; 95% confidence interval [CI]: 0.029, 0.114), followed by the Arsenicum album (aOR: 0.337; 95% CI: 0.238, 0.475) and Influenzinum (aOR: 0.539; 95% CI: 0.401, 0.726) groups.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Prespecified homeopathic medicines, particularly Oscillococcinum® and Arsenicum album 30C, may have a role in preventing COVID-19, especially in reducing the incidence of suspected or COVID-19-like respiratory illnesses. However, the result failed to demonstrate a statistically significant difference in the occurrence of confirmed cases of COVID-19 between the study groups. Further research is needed to evaluate the efficacy of these medicines in different populations and settings.&lt;/p&gt;&lt;p&gt;&lt;p&gt;&lt;title&gt;Einleitung&lt;/title&gt;Homöopathische Arzneimittel werden seit Jahrzehnten zur Prävention und Behandlung von Infektionskrankheiten eingesetzt. Die Wirksamkeit spezifischer homöopathischer Arzneimittel zur Prophylaxe von COVID-19 ist jedoch nicht gut untersucht. Mit dieser Studie sollte die vergleichende Wirksamkeit spezifischer homöopathischer Arzneimittel bei der Prävention von COVID-19 untersucht werden.&lt;title&gt;Methoden&lt;/title&gt;Es handelte sich um eine gemeindebasierte, doppelblinde, randomisierte, placebokontrollierte Studie mit 4.034 Teilnehmern, die im Bezirk Nr. 27 der Howrah Municipal Corporation in Indien lebten. Die Teilnehmer erhielten randomisiert eines von drei zuvor festgelegten homöopathischen Arzneimitteln [&lt;italic&gt;Influenzinum&lt;/italic&gt; 30C, &lt;italic&gt;Arsenicum album&lt;/italic&gt; 30C, &lt;italic&gt;Anas barbariae hepatis et cordis extrac","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"140-148"},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139575454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of Herbal Therapy Methods Used by Parents of Children with Cancer for Symptom Management in Chemotherapy Process. 癌症患儿家长在化疗过程中使用草药治疗方法控制症状的调查。
IF 1.1 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-10-04 DOI: 10.1159/000541708
Nurcan Erbay, Nejla Canbulat Sahiner, Mehmet Fatih Aydın

Introduction: The number of types of cancer, which is the leading severe health problem and is frequently seen in childhood period, has steadily increased over the years. This descriptive and cross-sectional study was conducted to determine the herbal treatment methods used by parents of children with cancer during the chemotherapy process for symptom management.

Methods: The study was carried out with the parents of 126 children diagnosed with cancer. The data were collected with a questionnaire form created in line with the literature and the form for the amount and frequency of use of herbal treatment methods used by parents. The data were evaluated with descriptive statistics and χ2 test.

Results: The mean age of the children included in the study was 8.08 ± 3.15 (min = 3, max = 17) years, and the mean duration of diagnosis was 14.35 ± 13.22 (min = 6, max = 60) months. 78.6% (n = 99) of the parents included in the study stated that they used herbal treatment for the treatment of their child's disease. 79.4% (n = 100) of the parents thought that the herbal treatment they used was effective. The first reason (48.4%, n = 61) for using herbal treatment was "to do everything we could for the treatment."

Conclusion: It was determined that the use of herbal treatment methods was related to the mother's profession, the education level of the parents, and the place of residence. In particular, it is necessary to inform parents about herbal treatment methods through nurses with up-to-date information and to create the right attitude toward this issue.

导 言癌症是儿童时期常见的严重健康问题,其类型数量近年来稳步增加。这项描述性横断面研究旨在了解癌症患儿父母在化疗过程中为控制症状而使用的草药治疗方法:研究对象为 126 名癌症患儿的家长。根据文献和家长使用草药治疗方法的数量和频率制作的调查表收集数据。通过描述性统计和卡方检验对数据进行了评估:参与研究的儿童平均年龄为(8.08±3.15)岁(最小=3 岁,最大=17 岁),平均诊断时间为(14.35±13.22)个月(最小=6 个月,最大=60 个月)。78.6%(n=99)的参与研究的家长表示,他们使用中草药治疗孩子的疾病。79.4%(n=100)的家长认为他们使用的中草药治疗有效。使用中草药治疗的首要原因(48.4%,n=61)是 "尽一切可能进行治疗":结论:使用草药治疗方法与母亲的职业、父母的教育水平和居住地有关。特别是,有必要通过护士向家长介绍草药治疗方法的最新信息,并树立对这一问题的正确态度。
{"title":"Investigation of Herbal Therapy Methods Used by Parents of Children with Cancer for Symptom Management in Chemotherapy Process.","authors":"Nurcan Erbay, Nejla Canbulat Sahiner, Mehmet Fatih Aydın","doi":"10.1159/000541708","DOIUrl":"10.1159/000541708","url":null,"abstract":"<p><strong>Introduction: </strong>The number of types of cancer, which is the leading severe health problem and is frequently seen in childhood period, has steadily increased over the years. This descriptive and cross-sectional study was conducted to determine the herbal treatment methods used by parents of children with cancer during the chemotherapy process for symptom management.</p><p><strong>Methods: </strong>The study was carried out with the parents of 126 children diagnosed with cancer. The data were collected with a questionnaire form created in line with the literature and the form for the amount and frequency of use of herbal treatment methods used by parents. The data were evaluated with descriptive statistics and χ2 test.</p><p><strong>Results: </strong>The mean age of the children included in the study was 8.08 ± 3.15 (min = 3, max = 17) years, and the mean duration of diagnosis was 14.35 ± 13.22 (min = 6, max = 60) months. 78.6% (n = 99) of the parents included in the study stated that they used herbal treatment for the treatment of their child's disease. 79.4% (n = 100) of the parents thought that the herbal treatment they used was effective. The first reason (48.4%, n = 61) for using herbal treatment was \"to do everything we could for the treatment.\"</p><p><strong>Conclusion: </strong>It was determined that the use of herbal treatment methods was related to the mother's profession, the education level of the parents, and the place of residence. In particular, it is necessary to inform parents about herbal treatment methods through nurses with up-to-date information and to create the right attitude toward this issue.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"529-539"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142380221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Volitionally Regulated Breathing with Prolonged Expiration Influences Food Craving and Impulsivity. 长时间呼气的调节性呼吸会影响对食物的渴望和冲动性。
IF 1.1 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-07-17 DOI: 10.1159/000539618
Shirley Telles, Ami Gupta, Sachin Kumar Sharma, Acharya Balkrishna

Introduction: Previously, an intervention involving volitional slow breathing reduced trait food craving with protective effects on cardiac vagal activity (CVA). Breathing with a low inspiration-to-expiration (i/e) ratio also increases CVA. High CVA was separately associated with low unregulated eating and lesser impulsivity. Hence, the present study assessed breathing with a low i/e for effects on state food craving, hunger and satiety, state impulsivity, and heart rate variability (HRV) in healthy obese persons.

Methods: Forty obese persons were randomized to two groups. The intervention group (mean age ± SD, 41.15 ± 12.63, M:F, 10:10) practiced metronome-regulated breathing with low i/e at 12 breaths per minute (expiration 72% of total breath duration) and attained expiration 55.8% of total breath duration, while the active control group (mean age ± SD, 44.45 ± 11.06, M:F, 13:07) sat motionless and directed their gaze and awareness to the stationary metronome without modifying their breath consciously. The HRV was recorded before, during, and after breathing intervention (or control) (standard limb lead I, acquisition at 2,000 Hz, with an LF filter = 0.5 Hz and HF filter = 50 Hz). Time-domain and frequency-domain HRV parameters were obtained with Kubios software. State food craving, and hunger and satiety were recorded before and after the intervention/control.

Results: The intervention group decreased total state food craving scores and the sub-domains (i.e., desire to eat, positive reinforcement, lack of control and hunger), increased current satisfaction with food, decreased total state impulsivity (repeated measures ANOVA, p < 0.05 in all cases), increased HF-HRV and RMSSD (linear mixed model analyses with age and gender as fixed factors; p < 0.05 in all cases) during the intervention compared to the preceding baseline. The intervention group also showed an increase in positive mood and a decrease in aroused and negative mood states.

Conclusion: Changes in state food craving and impulsivity could be related to an increase in HRV or to changes in subjective relaxation and positive mood or to both.

导言:以前,一种涉及自愿慢速呼吸的干预措施可减少特质食物渴求,对心脏迷走神经活动(CVA)具有保护作用。低吸气呼气比(i/e)呼吸也会增加心迷走神经活动。高 CVA 分别与低无节制进食和较少冲动有关。因此,本研究评估了低吸呼比呼吸对健康肥胖者的食物渴望、饥饿和饱腹感、状态冲动性和心率变异性(HRV)的影响。方法 将 40 名肥胖者随机分为两组。干预组(平均年龄(±SD),41.15±12.63,男:女,10:10)练习节拍器调节的低i/e呼吸,每分钟12次(呼气占总呼吸时间的72%)(bpm),达到呼气占总呼吸时间的55.8%;主动对照组(平均年龄(±SD),44.45±11.06,男:女,13:07)一动不动地坐着,将目光和意识投向静止的节拍器,不有意识地调整呼吸。在呼吸干预(或控制)之前、期间和之后记录心率变异(标准肢导联 I,采集频率为 2000 Hz,低频滤波器 = 0.5 Hz,高频滤波器 = 50 Hz。时域和频域心率变异参数由 Kubios 软件获得。记录干预/对照前后的食物渴求状态、饥饿感和饱腹感。结果 与之前的基线相比,干预组在干预期间降低了状态食物渴望的总分和各子域(即进食欲望、正强化、缺乏控制和饥饿感),提高了当前对食物的满意度,降低了状态冲动的总分(重复测量方差分析,所有情况下均为 p<0.05),提高了高频心率变异和 RMSSD(线性混合模型分析,年龄和性别为固定因素;所有情况下均为 p<0.05)。干预组的积极情绪也有所上升,而亢奋和消极情绪状态则有所下降。结论 食物渴求和冲动状态的变化可能与心率变异的增加有关,也可能与主观放松和积极情绪的变化有关,或者两者兼而有之。
{"title":"Volitionally Regulated Breathing with Prolonged Expiration Influences Food Craving and Impulsivity.","authors":"Shirley Telles, Ami Gupta, Sachin Kumar Sharma, Acharya Balkrishna","doi":"10.1159/000539618","DOIUrl":"10.1159/000539618","url":null,"abstract":"<p><strong>Introduction: </strong>Previously, an intervention involving volitional slow breathing reduced trait food craving with protective effects on cardiac vagal activity (CVA). Breathing with a low inspiration-to-expiration (i/e) ratio also increases CVA. High CVA was separately associated with low unregulated eating and lesser impulsivity. Hence, the present study assessed breathing with a low i/e for effects on state food craving, hunger and satiety, state impulsivity, and heart rate variability (HRV) in healthy obese persons.</p><p><strong>Methods: </strong>Forty obese persons were randomized to two groups. The intervention group (mean age ± SD, 41.15 ± 12.63, M:F, 10:10) practiced metronome-regulated breathing with low i/e at 12 breaths per minute (expiration 72% of total breath duration) and attained expiration 55.8% of total breath duration, while the active control group (mean age ± SD, 44.45 ± 11.06, M:F, 13:07) sat motionless and directed their gaze and awareness to the stationary metronome without modifying their breath consciously. The HRV was recorded before, during, and after breathing intervention (or control) (standard limb lead I, acquisition at 2,000 Hz, with an LF filter = 0.5 Hz and HF filter = 50 Hz). Time-domain and frequency-domain HRV parameters were obtained with Kubios software. State food craving, and hunger and satiety were recorded before and after the intervention/control.</p><p><strong>Results: </strong>The intervention group decreased total state food craving scores and the sub-domains (i.e., desire to eat, positive reinforcement, lack of control and hunger), increased current satisfaction with food, decreased total state impulsivity (repeated measures ANOVA, p &lt; 0.05 in all cases), increased HF-HRV and RMSSD (linear mixed model analyses with age and gender as fixed factors; p &lt; 0.05 in all cases) during the intervention compared to the preceding baseline. The intervention group also showed an increase in positive mood and a decrease in aroused and negative mood states.</p><p><strong>Conclusion: </strong>Changes in state food craving and impulsivity could be related to an increase in HRV or to changes in subjective relaxation and positive mood or to both.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"376-389"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nurturing Hope: Reproductive Outcomes with Sinosomatics following Unsuccessful in vitro Fertilization Attempts. 孕育希望:试管婴儿尝试失败后使用体外受精术的生殖结果。
IF 1.1 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-05-20 DOI: 10.1159/000539408
Antonia Pfeiffer, Annemarie Schweizer-Arau, Roxana M Popovici, Astrid Vogel, Yumiko von Hasselbach, Florian Beissner, Karin Meissner

Introduction: For women who have experienced failed attempts at in vitro fertilization (IVF) and face medical issues, leading to infertility, the renewed effort to seek fertility treatment, coupled with decreasing likelihood of success, can exert substantial emotional and physical strains. Consequently, many couples opt to discontinue treatment before attaining pregnancy. The objective of this study was to evaluate the reproductive outcomes in patients with unsuccessful prior IVF attempts who received a complementary treatment designed to alleviate emotional distress and burden.

Patients and methods: A retrospective analysis of data from infertile patients who initiated the complementary intervention at a private clinic between January 2014 and December 2016 was conducted. Information on diagnosis, history of infertility, prior assisted reproductive technology treatments, mode of conception, and pregnancy outcomes were retrieved.

Results: The data of 133 patients with a history of one or more unsuccessful IVF treatments were analyzed. Patients had an average age of 36.7 years (±4.4 SD) and had been experiencing infertility for an average of 4.6 years (±2.7 SD). The two main causes of their infertility were endometriosis (36.1%, 48 patients) and diminished egg quality (31.6%, 42 patients). By May 2020, a significant proportion of the patients, 81.2% (108 patients), had achieved pregnancy, leading to 94 live births, which represents a 70.7% success rate. These pregnancies mostly resulted from natural cycle IVF (35.1%), donor cycles (23.4%), and conventional IVF (21.3%). The dropout rate was comparatively low at 23.3%. The median time from the start of complementary treatment to delivery was 18 months, with a range of 12-28 months.

Conclusions: This study highlights the potential value of complementary treatment approaches in conjunction with standard medical care for women who have experienced unsuccessful IVF treatments in the past and thus face a reduced chance of motherhood. The reported 71% live birth rate is notably high, indicating that the inclusion of complementary treatments may provide women with past IVF failures a tangible opportunity for achieving successful pregnancy and childbirth. However, these findings need to be confirmed through randomized controlled studies.

导言:对于尝试过体外受精(IVF)失败并面临导致不孕的医疗问题的妇女来说,重新努力寻求生育治疗,再加上成功的可能性越来越小,会给她们带来巨大的精神和身体压力。因此,许多夫妇在怀孕前选择中止治疗。本研究的目的是评估曾尝试试管婴儿但未成功的患者接受旨在减轻情绪困扰和负担的辅助治疗后的生育结果:本研究对 2014 年 1 月至 2016 年 12 月期间在一家私人诊所接受辅助治疗的不孕不育患者的数据进行了回顾性分析。检索了有关诊断、不孕症病史、之前的辅助生殖技术治疗、受孕方式和妊娠结果的信息:对133名曾有一次或多次试管婴儿治疗失败史的患者的数据进行了分析。患者平均年龄为 36.7 岁(± 4.4 SD),平均不孕时间为 4.6 年(± 2.7 SD)。导致他们不孕的两个主要原因是子宫内膜异位症(36.1%,48 名患者)和卵子质量下降(31.6%,42 名患者)。截至 2020 年 5 月,大部分患者(81.2%,108 人)已成功怀孕,活产 94 例,成功率为 70.7%。这些妊娠大多来自自然周期试管婴儿(35.1%)、捐献周期试管婴儿(23.4%)和传统试管婴儿(21.3%)。辍学率相对较低,为 23.3%。从开始辅助治疗到分娩的中位时间为 18 个月,范围在 12 到 28 个月之间:这项研究强调了辅助治疗方法与标准医疗护理相结合的潜在价值,适用于过去试管婴儿治疗不成功、因而做母亲的机会减少的妇女。据报道,71%的活产率非常高,这表明,辅助治疗的加入可能会为过去试管婴儿治疗失败的妇女提供一个成功怀孕和分娩的切实机会。不过,这些发现还需要通过随机对照研究来证实。
{"title":"Nurturing Hope: Reproductive Outcomes with Sinosomatics following Unsuccessful in vitro Fertilization Attempts.","authors":"Antonia Pfeiffer, Annemarie Schweizer-Arau, Roxana M Popovici, Astrid Vogel, Yumiko von Hasselbach, Florian Beissner, Karin Meissner","doi":"10.1159/000539408","DOIUrl":"10.1159/000539408","url":null,"abstract":"<p><strong>Introduction: </strong>For women who have experienced failed attempts at in vitro fertilization (IVF) and face medical issues, leading to infertility, the renewed effort to seek fertility treatment, coupled with decreasing likelihood of success, can exert substantial emotional and physical strains. Consequently, many couples opt to discontinue treatment before attaining pregnancy. The objective of this study was to evaluate the reproductive outcomes in patients with unsuccessful prior IVF attempts who received a complementary treatment designed to alleviate emotional distress and burden.</p><p><strong>Patients and methods: </strong>A retrospective analysis of data from infertile patients who initiated the complementary intervention at a private clinic between January 2014 and December 2016 was conducted. Information on diagnosis, history of infertility, prior assisted reproductive technology treatments, mode of conception, and pregnancy outcomes were retrieved.</p><p><strong>Results: </strong>The data of 133 patients with a history of one or more unsuccessful IVF treatments were analyzed. Patients had an average age of 36.7 years (±4.4 SD) and had been experiencing infertility for an average of 4.6 years (±2.7 SD). The two main causes of their infertility were endometriosis (36.1%, 48 patients) and diminished egg quality (31.6%, 42 patients). By May 2020, a significant proportion of the patients, 81.2% (108 patients), had achieved pregnancy, leading to 94 live births, which represents a 70.7% success rate. These pregnancies mostly resulted from natural cycle IVF (35.1%), donor cycles (23.4%), and conventional IVF (21.3%). The dropout rate was comparatively low at 23.3%. The median time from the start of complementary treatment to delivery was 18 months, with a range of 12-28 months.</p><p><strong>Conclusions: </strong>This study highlights the potential value of complementary treatment approaches in conjunction with standard medical care for women who have experienced unsuccessful IVF treatments in the past and thus face a reduced chance of motherhood. The reported 71% live birth rate is notably high, indicating that the inclusion of complementary treatments may provide women with past IVF failures a tangible opportunity for achieving successful pregnancy and childbirth. However, these findings need to be confirmed through randomized controlled studies.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"367-375"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11343086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141070901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fasting in Science and Clinics: A Report on Proceedings from the International Scientific Symposium and Conference on Fasting in Berlin (June 2023). 科学和临床中的禁食--柏林禁食国际科学研讨会和会议(2023 年 6 月)记录报告。
IF 1.1 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-08-09 DOI: 10.1159/000540668
Carolin Breinlinger, Sara Meiß, Etienne Hanslian, Stefan Jordan, Michael Boschmann, Anika Rajput Khokhar, Andreas Michalsen, Daniela A Koppold

Background: A fasting conference and scientific symposium on fasting were held in Berlin in June 2023. Researchers and clinicians from around the world shared new findings, clinical insights, and work in progress during a 3-day program.

Summary: Different fasting regimens, including prolonged, short-term, intermittent fasting, and time-restricted eating were discussed for preventive and therapeutic settings. Experimental and clinical findings shared ranged from biochemical and cellular fasting responses to fasting-mimicking agents, the role of the gut microbiome, and immunological effects. Clinically, a special focus was placed upon metabolic, autoimmune, neurodegenerative, and oncological diseases. The discussion also covered how modern technologies, practical adaptations to traditional protocols, and a supportive network of specialized physicians can assist in the practical application of fasting, among other subjects.

Key messages: Dose-response relationships, gender aspects, and the subjective experience of fasting seem promising for future research, while further investigation of religious fasting may offer deeper insights into motivational and health aspects.

背景:2023 年 6 月在柏林举行了禁食会议和禁食科学研讨会。来自世界各地的研究人员和临床医生在为期三天的会议中分享了新发现、临床见解和工作进展。摘要:会议讨论了不同的禁食方案,包括长期、短期、间歇性禁食和限时进食(TRE),用于预防和治疗。分享的实验和临床研究结果包括生化和细胞禁食反应、禁食模拟药剂、肠道微生物组的作用和免疫学效应。在临床方面,会议特别关注代谢性疾病、自身免疫性疾病、神经退行性疾病和肿瘤疾病。讨论还涉及现代技术、对传统方案的实际调整、专业医生支持网络如何帮助禁食的实际应用等主题:关键信息:剂量-反应关系、性别因素和禁食的主观体验似乎是未来研究的前景所在,而对宗教禁食的进一步调查可能会为动机和健康方面提供更深入的见解。
{"title":"Fasting in Science and Clinics: A Report on Proceedings from the International Scientific Symposium and Conference on Fasting in Berlin (June 2023).","authors":"Carolin Breinlinger, Sara Meiß, Etienne Hanslian, Stefan Jordan, Michael Boschmann, Anika Rajput Khokhar, Andreas Michalsen, Daniela A Koppold","doi":"10.1159/000540668","DOIUrl":"10.1159/000540668","url":null,"abstract":"<p><strong>Background: </strong>A fasting conference and scientific symposium on fasting were held in Berlin in June 2023. Researchers and clinicians from around the world shared new findings, clinical insights, and work in progress during a 3-day program.</p><p><strong>Summary: </strong>Different fasting regimens, including prolonged, short-term, intermittent fasting, and time-restricted eating were discussed for preventive and therapeutic settings. Experimental and clinical findings shared ranged from biochemical and cellular fasting responses to fasting-mimicking agents, the role of the gut microbiome, and immunological effects. Clinically, a special focus was placed upon metabolic, autoimmune, neurodegenerative, and oncological diseases. The discussion also covered how modern technologies, practical adaptations to traditional protocols, and a supportive network of specialized physicians can assist in the practical application of fasting, among other subjects.</p><p><strong>Key messages: </strong>Dose-response relationships, gender aspects, and the subjective experience of fasting seem promising for future research, while further investigation of religious fasting may offer deeper insights into motivational and health aspects.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"484-491"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11466443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141916239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Honey-Lime Spray as Add-On Therapy on Chemotherapy-Induced Xerostomia in Breast Cancer Patients: A Pilot Randomized Double-Blinded Controlled Trial. 蜂蜜石灰喷雾剂作为附加疗法对乳腺癌患者化疗引起的口干舌燥的影响:随机双盲对照试验。
IF 1.8 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-01-24 DOI: 10.1159/000536226
Ghazaleh Heydarirad, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Samira Ghorbanpoor, Judith Buentzel, Thomas Rampp, Mehdi Pasalar
<p><strong>Introduction: </strong>Xerostomia (dry mouth) is a common side effect among patients with cancer undergoing chemotherapy. There is no standard treatment for this symptom yet, although Persian medicine textbooks suggested some products to relieve xerostomia. We aimed to assess the efficacy of honey-lime spray in treating chemotherapy-induced xerostomia in breast cancer patients through a controlled study.</p><p><strong>Methods: </strong>In this pilot, randomized, double-blinded clinical trial conducted in Shohadaye Tajrish Hospital, Iran, the intervention group received honey-lime spray and nystatin, while the control group used distilled water plus nystatin for 2 weeks. The six-item dry mouth form and visual analog score (VAS) were used to evaluate xerostomia extent and pain, respectively.</p><p><strong>Results: </strong>The standardized value of the difference between the mean scores before and after the study was -10.21 (p < 0.001), and the effect size was estimated at 55%. Also, VAS showed a significant decrease in pain for the intervention group compared with the control group (p < 0.001). There were no serious side effects.</p><p><strong>Conclusion: </strong>Honey-lime spray may be a good treatment choice for xerostomia in chemotherapy-induced breast cancer patients, but robust trials with larger samples and prolonged follow-ups are highly recommended.</p><p><p><title>Einleitung</title>Mundtrockenheit (Xerostomie) ist eine häufige Nebenwirkung bei Krebspatienten, die sich einer Chemotherapie unterziehen. Es gibt bisher keine Standardtherapie für dieses Symptom, doch Lehrbücher der persischen Medizin schlagen einige Mittel zur Linderung von Mundtrockenheit vor. Unser Ziel war es, die Wirksamkeit von Honig-Limetten-Spray zur Behandlung von chemotherapiebedingter Mundtrockenheit bei Patientinnen mit Brustkrebs im Rahmen einer kontrollierten Studie zu untersuchen.<title>Methoden</title>In dieser randomisierten, doppelt verblindeten klinischen Pilotstudie, die im Shohadaye Tajrish Hospital im Iran durchgeführt wurde, erhielt die Interventionsgruppe zwei Wochen lang Honig-Limetten-Spray und Nystatin und die Kontrollgruppe destilliertes Wasser plus Nystatin. Ein Mundtrockenheits-Fragebogen mit sechs Items wurde zur Beurteilung der Schwere der Mundtrockenheit verwendet und eine visuelle Analogskala zur Beurteilung der Schmerzen.<title>Ergebnisse</title>Der standardisierte Wert der Differenz zwischen den mittleren Scores vor und nach der Studie betrug −10,21 (<italic>p</italic> < 0,01), und die geschätzte Effektstärke betrug 55%. Zudem zeigte die VAS eine signifikante Abnahme der Schmerzen in der Interventionsgruppe im Vergleich zur Kontrollgruppe (<italic>p</italic> < 0,01). Es traten keine schwerwiegenden Nebenwirkungen auf.<title>Schlussfolgerung</title>Honig-Limetten-Spray könnte eine gute Wahl für die Behandlung von Mundtrockenheit bei Brustkrebspatientinnen unter Chemotherapie sein, doch hierzu werden belastbare Studien m
简介口干症(口腔干燥)是接受化疗的癌症患者常见的副作用。虽然波斯医学教科书建议使用一些产品来缓解口干症,但目前还没有针对这一症状的标准治疗方法。我们旨在通过一项对照研究,评估蜂蜜石灰喷雾剂治疗乳腺癌患者化疗引起的口干舌燥的疗效:在伊朗 Shohadaye Tajrish 医院进行的这项试验性、随机、双盲临床试验中,干预组使用蜂蜜石灰喷雾剂和硝苯地平,对照组使用蒸馏水和硝苯地平,为期两周。结果显示,干预组和对照组的口干程度和疼痛程度差异的标准化值分别为 0.05 和 0.05,而对照组为 0.05 和 0.05:结果:研究前后的平均分差值的标准化值为-10.21(PC结论:蜂蜜石灰喷雾剂可能是一种很好的治疗方法:蜂蜜石灰喷雾剂可能是治疗化疗引起的乳腺癌患者口干症的良好选择,但强烈建议进行更大规模的样本试验和更长时间的随访。
{"title":"Effect of Honey-Lime Spray as Add-On Therapy on Chemotherapy-Induced Xerostomia in Breast Cancer Patients: A Pilot Randomized Double-Blinded Controlled Trial.","authors":"Ghazaleh Heydarirad, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Samira Ghorbanpoor, Judith Buentzel, Thomas Rampp, Mehdi Pasalar","doi":"10.1159/000536226","DOIUrl":"10.1159/000536226","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Xerostomia (dry mouth) is a common side effect among patients with cancer undergoing chemotherapy. There is no standard treatment for this symptom yet, although Persian medicine textbooks suggested some products to relieve xerostomia. We aimed to assess the efficacy of honey-lime spray in treating chemotherapy-induced xerostomia in breast cancer patients through a controlled study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;In this pilot, randomized, double-blinded clinical trial conducted in Shohadaye Tajrish Hospital, Iran, the intervention group received honey-lime spray and nystatin, while the control group used distilled water plus nystatin for 2 weeks. The six-item dry mouth form and visual analog score (VAS) were used to evaluate xerostomia extent and pain, respectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The standardized value of the difference between the mean scores before and after the study was -10.21 (p &lt; 0.001), and the effect size was estimated at 55%. Also, VAS showed a significant decrease in pain for the intervention group compared with the control group (p &lt; 0.001). There were no serious side effects.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Honey-lime spray may be a good treatment choice for xerostomia in chemotherapy-induced breast cancer patients, but robust trials with larger samples and prolonged follow-ups are highly recommended.&lt;/p&gt;&lt;p&gt;&lt;p&gt;&lt;title&gt;Einleitung&lt;/title&gt;Mundtrockenheit (Xerostomie) ist eine häufige Nebenwirkung bei Krebspatienten, die sich einer Chemotherapie unterziehen. Es gibt bisher keine Standardtherapie für dieses Symptom, doch Lehrbücher der persischen Medizin schlagen einige Mittel zur Linderung von Mundtrockenheit vor. Unser Ziel war es, die Wirksamkeit von Honig-Limetten-Spray zur Behandlung von chemotherapiebedingter Mundtrockenheit bei Patientinnen mit Brustkrebs im Rahmen einer kontrollierten Studie zu untersuchen.&lt;title&gt;Methoden&lt;/title&gt;In dieser randomisierten, doppelt verblindeten klinischen Pilotstudie, die im Shohadaye Tajrish Hospital im Iran durchgeführt wurde, erhielt die Interventionsgruppe zwei Wochen lang Honig-Limetten-Spray und Nystatin und die Kontrollgruppe destilliertes Wasser plus Nystatin. Ein Mundtrockenheits-Fragebogen mit sechs Items wurde zur Beurteilung der Schwere der Mundtrockenheit verwendet und eine visuelle Analogskala zur Beurteilung der Schmerzen.&lt;title&gt;Ergebnisse&lt;/title&gt;Der standardisierte Wert der Differenz zwischen den mittleren Scores vor und nach der Studie betrug −10,21 (&lt;italic&gt;p&lt;/italic&gt; &lt; 0,01), und die geschätzte Effektstärke betrug 55%. Zudem zeigte die VAS eine signifikante Abnahme der Schmerzen in der Interventionsgruppe im Vergleich zur Kontrollgruppe (&lt;italic&gt;p&lt;/italic&gt; &lt; 0,01). Es traten keine schwerwiegenden Nebenwirkungen auf.&lt;title&gt;Schlussfolgerung&lt;/title&gt;Honig-Limetten-Spray könnte eine gute Wahl für die Behandlung von Mundtrockenheit bei Brustkrebspatientinnen unter Chemotherapie sein, doch hierzu werden belastbare Studien m","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"133-139"},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139545089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Complementary Medicine Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1